Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis
Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis
复制标题
DOI:
10.1093/rheumatology/kep300
复制
发表时间:
2009-12-01
期刊:
影响因子:
5.5
通讯作者:
Martel-Pelletier, Johanne
中科院分区:
文献类型:
--
作者:
Tat, Steeve Kwan;Amiable, Nathalie;Martel-Pelletier, Johanne
Objectives. Earlier studies suggest the involvement of osteoprotegerin (OPG), RANK and RANK ligand (RANKL) in OA subchondral bone metabolism; however, few studies have looked at their functional consequences on chondrocytes. We compared the expression/production of OPG, RANK and RANKL on human normal and OA chondrocytes, and evaluated, on OA chondrocytes, their modulation by some catabolic factors. Furthermore, the role of OPG and RANKL on the production of catabolic/anabolic factors was assessed.Methods. Expression was determined using real-time PCR, production of RANK and RANKL by flow cytometry and that of OPG by ELISA. Modulation of these factors was determined upon treatment with IL-1 beta, TNF-alpha and PGE(2). The functional consequences were examined following treatment with soluble RANKL or OPG-Fc (OPG without the heparin-binding domain).Results. OPG, RANK and RANKL were expressed and produced by human chondrocytes. Membranous RANK was produced only by an OA chondrocyte subpopulation (29%) localized throughout the cartilage. The OPG/RANKL ratio was significantly (P=0.05)reduced on the OA chondrocytes, whereas the RANK/RANKL ratio was significantly (P